Page last updated at 10:15 GMT, Wednesday, 18 March 2009

Drugs firm upbeat despite losses

Sancuso patch
The Sancuso patch recently received approval in the US

A Scottish pharmaceutical firm has forecast rapid future growth despite making a 20m pre-tax loss last year.

Galashiels-based ProStrakan said 2008 had been an "excellent year" for the company with product sales rising 32% and total revenue up 23%.

Chief Executive Dr Wilson Totten said he was confident the firm would reach a break-even position this year.

He added that deals for a number of its products could underpin business growth in both the US and Europe.

The Borders company's preliminary results for last year show a pre-tax loss of 21.3m compared with a 17.6m loss in 2007.

'Major milestone'

However, both product sales and total revenues have risen significantly.

The US launch of Sancuso - a skin patch to combat nausea in patients undergoing chemotherapy - was seen as a "major milestone" for the company.

It also hopes to see further expansion in sales of its cancer pain-relief treatment Abstral.

As well as unveiling its 2008 results, ProStrakan also announced another co-promotion deal in the US for a mouth gel for people receiving chemotherapy.

Print Sponsor

Cancer pain drug deals approved
02 Mar 09 |  South of Scotland
US market launch for cancer patch
03 Nov 08 |  South of Scotland
Cancer patch firm secures US deal
15 Sep 08 |  South of Scotland
Borders firm nets 74m drug deal
28 Sep 06 |  South of Scotland
East European deal for drugs firm
27 Jul 06 |  South of Scotland
Scots firm announces huge US deal
14 Jul 06 |  South of Scotland

The BBC is not responsible for the content of external internet sites

Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit


Sign in

BBC navigation

Copyright © 2019 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific